Abstract
A microsuspension of Delta(9)-tetrahydrocannabinol and of its metabolic derivative 11-OH-Delta(9)-tetrahydrocannabinol has been prepared with 25 percent human serum albumin as the vehicle. Intravenous infusion of this preparation to humans indicates that both tetrahydrocannabinols are equally potent in producing the typical marihuana-like pschological and physiological effects.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Adult
-
Cannabis / administration & dosage*
-
Clinical Trials as Topic
-
Dronabinol / administration & dosage
-
Dronabinol / pharmacology
-
Emotions / drug effects
-
Heart Rate / drug effects
-
Humans
-
Injections, Intravenous
-
Male
-
Pharmaceutical Vehicles
-
Phytotherapy*
-
Placebos
-
Serum Albumin
Substances
-
Pharmaceutical Vehicles
-
Placebos
-
Serum Albumin
-
Dronabinol